Search research articles
Contact Us
Filters
Showing results (81-90 of 112) with videos related to
Page
of 12
Sort By:
Pharmacoepidemiology and Drug Safety
|
January 4, 2020
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
Daniel R Morales, Steve V Morant, Thomas M MacDonald, et al.
British Journal of Clinical Pharmacology
|
July 16, 2020
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis
Daniel R Morales, Steven V Morant, Thomas M MacDonald, et al.
Journal of the American College of Cardiology
|
April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
Fan Bu, Ruopeng Wu, Anna Ostropolets, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
November 17, 2022
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries
F Lucy Wright, Kate Cheema, Raph Goldacre, et al.
European Journal of Internal Medicine
|
August 12, 2024
Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries
Mike Du, Francesco Dernie, Martí Català, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
Akihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Drug Safety
|
June 2, 2022
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
Azza Shoaibi, Gowtham A Rao, Erica A Voss, et al.
Frontiers in Pharmacology
|
October 3, 2022
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
Akihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Eclinicalmedicine
|
February 20, 2025
Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study
Jack L Janetzki, Jung Ho Kim, Evan Minty, et al.
Diabetes Care
|
June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study
Daniel R Morales, Fan Bu, Benjamin Viernes, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 112) with videos related to
Sort By:
Page
of 12
Pharmacoepidemiology and Drug Safety
|
January 4, 2020
Impact of EMA regulatory label changes on systemic diclofenac initiation, discontinuation, and switching to other pain medicines in Scotland, England, Denmark, and The Netherlands
Daniel R Morales, Steve V Morant, Thomas M MacDonald, et al.
British Journal of Clinical Pharmacology
|
July 16, 2020
Impact of EU regulatory label changes for diclofenac in people with cardiovascular disease in four countries: Interrupted time series regression analysis
Daniel R Morales, Steven V Morant, Thomas M MacDonald, et al.
Journal of the American College of Cardiology
|
April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes Mellitus
Fan Bu, Ruopeng Wu, Anna Ostropolets, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
November 17, 2022
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries
F Lucy Wright, Kate Cheema, Raph Goldacre, et al.
European Journal of Internal Medicine
|
August 12, 2024
Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries
Mike Du, Francesco Dernie, Martí Català, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
Akihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Drug Safety
|
June 2, 2022
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
Azza Shoaibi, Gowtham A Rao, Erica A Voss, et al.
Frontiers in Pharmacology
|
October 3, 2022
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
Akihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Eclinicalmedicine
|
February 20, 2025
Risk of aortic aneurysm or dissection following use of fluoroquinolones: a retrospective multinational network cohort study
Jack L Janetzki, Jung Ho Kim, Evan Minty, et al.
Diabetes Care
|
June 4, 2025
Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study
Daniel R Morales, Fan Bu, Benjamin Viernes, et al.
Page
of 12